Salivary IL ‐33 and sST2 levels in relation to TLR2 rs111200466 polymorphism and periodontitis
Oral Diseases · 2024
DOI: 10.1111/odi.14675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Mustafa Yilmaz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Institute of Dentistry, University of Turku, Turku, Finland. Hauptthemen laut MEDLINE: Interleukin-33, Toll-Like Receptor 2, Interleukin-1 Receptor-Like 1 Protein, Saliva. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Minerva Foundation, Suomen Hammaslääkäriseura Apollonia, Tampereen Tuberkuloosisäätiö.
Abstract (Originalsprache)
Objectives
Toll‐like receptor‐2 (TLR2) signalling pathway is involved in the regulation of interleukin (IL)‐33 and its receptor suppression of tumorigenicity‐2 (ST2). This study aimed to compare salivary IL‐33 and soluble ST2 (sST2) levels of periodontitis patients with those of periodontally healthy individuals in relation to their TLR2 rs111200466 23‐bp insertion/deletion polymorphism within the promoter region. Materials and Methods Unstimulated saliva samples were collected, and periodontal parameters were recorded from 35 periodontally healthy individuals and 44 periodontitis patients. Non‐surgical treatments were applied to periodontitis patients, and sample collections and clinical measurements were repeated 3 months following therapy. Salivary IL‐33 and sST2 levels were measured with enzyme‐linked immunosorbent assay kits, and TLR2 rs111200466 polymorphism was detected by polymerase chain reaction.
Results
Elevated salivary IL‐33 ( p = 0.007) and sST2 ( p = 0.020) levels were observed in periodontitis patients, in comparison to controls. sST2 levels declined 3‐months following treatment ( p < 0.001). Increased salivary IL‐33 and sST2 levels were found to be associated with periodontitis, with no significant relation to the TLR2 polymorphism.
Conclusion
Periodontitis, but not TLR2 rs111200466 polymorphism, is associated with elevated salivary sST2 and possibly IL‐33 levels, and periodontal treatment is effective in reducing salivary sST2 levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontology, Institute of Dentistry, University of Turku, Turku, Finland.
- Department of Periodontology, Faculty of Dentistry, Biruni University, Istanbul, Turkey.
- Institute of Biomedicine, Research Centre for Infections and Immunity, University of Turku, Turku, Finland.
- InFLAMES Research Flagship Centre, University of Turku, Turku, Finland.
- Department of Periodontology, Faculty of Dentistry, Bezmialem Vakif University, Istanbul, Turkey.
ORCID-Profile: Mustafa Yilmaz, Esra Demir
Förderung
- Minerva Foundation
- Suomen Hammaslääkäriseura Apollonia
- Tampereen Tuberkuloosisäätiö
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
Zitieren
APA
Yilmaz, M., He, Q., Demir, E., Teräsjärvi, J., & Gürsoy, U. K. (2024). Salivary IL ‐33 and sST2 levels in relation to TLR2 rs111200466 polymorphism and periodontitis. Oral Diseases. https://doi.org/10.1111/odi.14675
Vancouver
Yilmaz M, He Q, Demir E, Teräsjärvi J, Gürsoy UK. Salivary IL ‐33 and sST2 levels in relation to TLR2 rs111200466 polymorphism and periodontitis. Oral Diseases. 2024. doi:10.1111/odi.14675
BibTeX
@article{Yilmaz2024,
author = {Yilmaz, Mustafa and He, Qiushui and Demir, Esra and Teräsjärvi, Johanna and Gürsoy, Ulvi Kahraman},
title = {Salivary IL ‐33 and sST2 levels in relation to TLR2 rs111200466 polymorphism and periodontitis},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14675}
}
EUVIMED